Veritable’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-31,128
Closed -$3.09M 847
2019
Q3
$3.09M Buy
31,128
+648
+2% +$61.6K 0.06% 165
2019
Q2
$2.82M Buy
30,480
+1,432
+5% +$136K 0.06% 173
2019
Q1
$2.74M Sell
29,048
-490
-2% -$42.9K 0.06% 174
2018
Q4
$1.89M Sell
29,538
-867
-3% -$64K 0.04% 207
2018
Q3
$2.72M Sell
30,405
-2,152
-7% -$190K 0.05% 175
2018
Q2
$2.59M Sell
32,557
-326
-1% -$27.1K 0.05% 173
2018
Q1
$2.93M Buy
32,883
+1,139
+4% +$109K 0.06% 163
2017
Q4
$3.31M Sell
31,744
-9,192
-22% -$1.04M 0.07% 154
2017
Q3
$5.97M Sell
40,936
-9,949
-20% -$1.36M 0.13% 111
2017
Q2
$6.61M Buy
50,885
+4,613
+10% +$565K 0.15% 99
2017
Q1
$5.76M Buy
46,272
+304
+0.7% +$36.4K 0.14% 104
2016
Q4
$5.32M Sell
45,968
-14,078
-23% -$1.57M 0.13% 107
2016
Q3
$6.28M Buy
60,046
+1,712
+3% +$185K 0.16% 91
2016
Q2
$5.75M Buy
58,334
+295
+0.5% +$30.5K 0.15% 98
2016
Q1
$5.81M Buy
58,039
+279
+0.5% +$28.7K 0.15% 98
2015
Q4
$6.92M Buy
57,760
+52
+0.1% +$6.02K 0.19% 83
2015
Q3
$6.24M Buy
57,708
+1,203
+2% +$149K 0.18% 83
2015
Q2
$6.54M Sell
56,505
-46,465
-45% -$5.31M 0.18% 88
2015
Q1
$11.9M Buy
102,970
+172
+0.2% +$20.6K 0.25% 64
2014
Q4
$11.5M Buy
102,798
+58
+0.1% +$6.12K 0.24% 70
2014
Q3
$9.74M Buy
102,740
+35,222
+52% +$3.18M 0.21% 82
2014
Q2
$5.8M Sell
67,518
-116
-0.2% -$8.82K 0.12% 128
2014
Q1
$4.72M Sell
67,634
-1,630
-2% -$129K 0.1% 145
2013
Q4
$5.85M Sell
69,264
-1,856
-3% -$147K 0.13% 126
2013
Q3
$5.48M Sell
71,120
-37,482
-35% -$2.63M 0.13% 125
2013
Q2
$6.35M Buy
+108,602
New +$6.54M 0.15% 111

Other funds holding CELG

Veritable's CELG Position: Q4 2019 in Review

Veritable sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 31,128 shares — an estimated $3.09M sold.

Veritable first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11.9M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Veritable reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Veritable sold 31,128 Celgene Corp shares in Q4 2019, an estimated $3.09M.
  • Veritable first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Veritable's Celgene Corp position peaked at $11.9M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Veritable's 13F filing for Q4 2019, filed 14 Feb 2020.